Skip to main content
VERO
OTC Industrial Applications And Services

EW Healthcare Sells $2.6M Preferred Shares & Debt to Madryn, Consolidating Control

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
9
Price
$0.337
Mkt Cap
$627.268K
52W Low
$0.247
52W High
$14.5
Market data snapshot near publication time

summarizeSummary

EW Healthcare Partners has finalized the sale of its preferred shares and convertible debt in Venus Concept to Madryn Asset Management for $2.6 million, a move that significantly consolidates Madryn's control and follows its prior proposal to take the company private.


check_boxKey Events

  • Major Stake Sale Finalized

    EW Healthcare Partners sold 1.5 million Junior Preferred Shares, 1.57 million Senior Preferred Shares, and Secured Subordinated Convertible Notes to Madryn Asset Management.

  • Significant Transaction Value

    The aggregate purchase price for these securities was $2.6 million, a value more than four times the company's current market capitalization.

  • Consolidation of Control

    This transaction significantly consolidates Madryn Asset Management's ownership and control over Venus Concept, following its prior proposal to take the company private.

  • Change in Collateral Agent

    EW Healthcare Partners resigned as Collateral Agent under the Note Purchase Agreement, with Madryn Health Partners appointed as the successor.


auto_awesomeAnalysis

This Schedule 13D/A provides the definitive terms of the previously announced agreement for EW Healthcare Partners to sell its preferred shares and convertible debt to Madryn Asset Management. The $2.6 million transaction value is substantial, exceeding Venus Concept's current market capitalization by over four times. This sale effectively transfers a significant portion of the company's capital structure to Madryn, which already holds a controlling stake and has proposed a short-form merger to take the company private. The consolidation of ownership by Madryn, coupled with EW Healthcare's resignation as Collateral Agent, streamlines Madryn's control over the company's financial instruments and strategic direction. This event is a critical step towards a potential take-private transaction, significantly impacting the investment thesis for existing common shareholders.

At the time of this filing, VERO was trading at $0.34 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $627.3K. The 52-week trading range was $0.25 to $14.50. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed VERO - Latest Insights

VERO
Mar 30, 2026, 9:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
10
VERO
Mar 30, 2026, 9:16 PM EDT
Filing Type: 4
Importance Score:
9
VERO
Mar 27, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
9
VERO
Mar 27, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
VERO
Mar 18, 2026, 5:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
VERO
Mar 17, 2026, 8:54 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
10
VERO
Feb 03, 2026, 7:15 AM EST
Filing Type: 8-K
Importance Score:
9
VERO
Jan 21, 2026, 7:35 AM EST
Filing Type: 8-K
Importance Score:
9
VERO
Jan 15, 2026, 4:30 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
VERO
Jan 07, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
9